[Remote] Head of Patient Data, Epidemiology and Patient Data Products at Valo Health

Lexington, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Passionate about leading high-impact teams
Ability to navigate ambiguous problems and right-size complex computational tasks
Experience delivering innovative machine learning/AI-enabled patient data products
Experience with real-world data (RWD) platforms
Experience with electronic health record data and RWD platform integration
Experience with feature engineering, data curation, and fit-for-purpose tooling
Experience with common data models
Experience with data validation/QC and automated systems
Experience with patient feature mapping and standardization
Experience with mentoring and career development

Responsibilities

Elevate Patient perspective in Drug Discovery and Development
Champion the Valo RWD user experience
Improve patient representation AI in RWD workflows
Lead Patient Data Asset Platform development and execution
Own RWD tooling roadmap
Partner with epidemiology and data science leaders to execute continuous evaluation of RWD data assets
Lead high-performing team, including roadmap development, mentoring, and career development
Foster a culture of excellence dedicated to scientific rigor and continuous learning
Align product initiatives with patient needs

Skills

Valo Health

Drug discovery using machine learning technology

About Valo Health

Valo Health focuses on drug discovery and development in the biopharmaceutical sector, utilizing advanced technology to create new drugs and therapies. The company employs its proprietary Opal Computational platform, which integrates machine learning, tissue biology, and patient data to streamline the drug discovery process. This platform allows Valo Health to identify potential drug candidates more quickly and accurately than traditional methods. Valo Health differentiates itself from competitors by combining technology with life sciences, fostering a collaborative culture that addresses significant challenges in drug development. The company's goal is to improve health outcomes for patients worldwide by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.

Boston, MassachusettsHeadquarters

2019Year Founded

$474.2MTotal Funding

LATE_VCCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Leadership changes may impact Valo's strategic direction and decision-making.

Heavy reliance on Novo Nordisk partnership poses financial risks if expectations aren't met.

Intensifying competition in AI-driven drug discovery could challenge Valo's market position.

Differentiation

Valo Health integrates AI and human-centric data for drug discovery and development.

The Opal Computational Platform offers an end-to-end solution for drug discovery.

Valo's approach combines machine learning, tissue biology, and patient data for precision therapeutics.

Upsides

Valo's partnership with Novo Nordisk could yield up to $4.6 billion in milestone payments.

The growing market for AI-driven drug discovery platforms supports Valo's business model.

Strategic partnerships with pharmaceutical companies enhance Valo's revenue and market reach.

Land your dream remote job 3x faster with AI

Try Jobo Free